Disposal Group, Including Discontinued Operation, Additional Period

No definition available.

Name:	ebs_DisposalGroupIncludingDiscontinuedOperationAdditionalPeriod
Namespace Prefix:	ebs_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	instant

- Definition

Disposal Group, Including Discontinued Operation, Change In Amount Of Contingent Consideration, Asset

+ References

No definition available.

+ Details

Name:	ebs_DisposalGroupIncludingDiscontinuedOperationChangeInAmountOfContingentConsiderationAsset
Namespace Prefix:	ebs_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Disposal Group, Including Discontinued Operation, Maximum Contingent Consideration Receivable

+ References

No definition available.

+ Details

Name:	ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable
Namespace Prefix:	ebs_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.

+ References

No definition available.

+ Details

Name:	us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Cash received for the settlement of litigation during the current period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 25
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-25

+ Details

Name:	us-gaap_ProceedsFromLegalSettlements
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481674/830-30-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 855
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483399/855-10-50-2

+ Details

Name:	us-gaap_SubsequentEventLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ebs_TravelHealthBusinessMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=ebs_DevelopmentBasedMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ebs_RSDLMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_MajorCustomersAxis=ebs_JansenPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Subsequent events (Details) - USD ($) $ in Millions	Jul. 31, 2024	Jul. 18, 2024	May 15, 2023
Disposal Group, Disposed of by Sale, Not Discontinued Operations \| Travel Health Business
Subsequent Event [Line Items]
Cash purchase price for sale of business			$ 270.2
Development-Based Milestones \| Disposal Group, Disposed of by Sale, Not Discontinued Operations \| Travel Health Business
Subsequent Event [Line Items]
Milestone payments receivable			$ 80.0
Subsequent Event \| Disposal Group, Disposed of by Sale, Not Discontinued Operations \| RSDL
Subsequent Event [Line Items]
Cash purchase price for sale of business	$ 75.0
Milestone payments receivable	$ 5.0
Disposal group, including discontinued operation, additional period	3 years
Subsequent Event \| Development-Based Milestones \| Disposal Group, Disposed of by Sale, Not Discontinued Operations \| Travel Health Business
Subsequent Event [Line Items]
Increase in contingent consideration, asset		$ 10.0
Jansen Pharmaceuticals, Inc. \| Subsequent Event
Subsequent Event [Line Items]
Proceeds from legal settlements	$ 50.0